Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2012 2
2013 2
2014 1
2016 2
2017 1
2018 1
2019 7
2020 5
2021 8
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Case report: Targeted treatment strategies for Erdheim-Chester disease.
Gulyás A, Pinczés LI, Mátyus J, Végh E, Bedekovics J, Tóth J, Barna S, Hunya Z, Szabó IL, Gazdag A, Illés Á, Magyari F. Gulyás A, et al. Among authors: vegh e. Front Oncol. 2024 Mar 14;14:1305518. doi: 10.3389/fonc.2024.1305518. eCollection 2024. Front Oncol. 2024. PMID: 38549927 Free PMC article.
Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis.
Kacsándi D, Fagyas M, Horváth Á, Végh E, Pusztai A, Czókolyová M, Soós B, Szabó AÁ, Hamar A, Pethő Z, Bodnár N, Kerekes G, Hodosi K, Szamosi S, Szűcs G, Papp Z, Szekanecz Z. Kacsándi D, et al. Among authors: vegh e. Front Med (Lausanne). 2023 Oct 9;10:1226760. doi: 10.3389/fmed.2023.1226760. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37877017 Free PMC article.
Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.
Kerekes G, Czókolyová M, Hamar A, Pusztai A, Tajti G, Katkó M, Végh E, Pethő Z, Bodnár N, Horváth Á, Soós B, Szamosi S, Hascsi Z, Harangi M, Hodosi K, Panyi G, Seres T, Szűcs G, Szekanecz Z. Kerekes G, et al. Among authors: vegh e. Rheumatology (Oxford). 2023 Oct 23;62(SI3):SI304-SI312. doi: 10.1093/rheumatology/kead502. Rheumatology (Oxford). 2023. PMID: 37871914 Free PMC article.
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B; SAPHYR Investigators. Spiera RF, et al. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. N Engl J Med. 2023. PMID: 37792612 Clinical Trial.
Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach.
Soós B, Hamar A, Pusztai A, Czókolyová M, Végh E, Szamosi S, Pethő Z, Gulyás K, Kerekes G, Szántó S, Szűcs G, Christians U, Klawitter J, Seres T, Szekanecz Z. Soós B, et al. Among authors: vegh e. Front Med (Lausanne). 2022 Nov 10;9:1011734. doi: 10.3389/fmed.2022.1011734. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36438060 Free PMC article.
Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis.
Czókolyová M, Hamar A, Pusztai A, Tajti G, Végh E, Pethő Z, Bodnár N, Horváth Á, Soós B, Szamosi S, Szentpéteri A, Seres I, Harangi M, Paragh G, Kerekes G, Bodoki L, Domján A, Hodosi K, Seres T, Panyi G, Szekanecz Z, Szűcs G. Czókolyová M, et al. Among authors: vegh e. Biomolecules. 2022 Oct 14;12(10):1483. doi: 10.3390/biom12101483. Biomolecules. 2022. PMID: 36291691 Free PMC article.
Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.
Soós B, Fagyas M, Horváth Á, Végh E, Pusztai A, Czókolyová M, Csongrádi A, Hamar A, Pethő Z, Bodnár N, Kerekes G, Hodosi K, Szekanecz É, Szamosi S, Szántó S, Szűcs G, Papp Z, Szekanecz Z. Soós B, et al. Among authors: vegh e. Front Med (Lausanne). 2022 Jan 27;8:785744. doi: 10.3389/fmed.2021.785744. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35155468 Free PMC article.
Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status.
Hamar A, Hascsi Z, Pusztai A, Czókolyová M, Végh E, Pethő Z, Gulyás K, Soós B, Kerekes G, Szekanecz É, Hodosi K, Szántó S, Szűcs G, Seres T, Szekanecz Z, Szamosi S. Hamar A, et al. Among authors: vegh e. RMD Open. 2021 Nov;7(3):e001804. doi: 10.1136/rmdopen-2021-001804. RMD Open. 2021. PMID: 34740980 Free PMC article. No abstract available.
33 results